August 2020

Volume 20 Issue 8

Editorial Staff

Clinical Editor
Bradley Knight, MD
Executive Editor
Laurie Gustafson
Managing Editor
Jodie Elrod
Production Manager
Alexa Flinn

Editorial Correspondence

Jodie Elrod, Managing Editor, EP Lab Digest
HMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (800) 371-0791

Fax: (866) 488-8273
Online advertisement sponsored by Cardiva Medical.
The cryoballoon (CB) is an effective tool to isolate the pulmonary veins (PVs), and has been shown to be a safe and effective ablation approach to prevent recurrent paroxysmal atrial fibrillation (pAF) in patients who have failed medical therapy.
In this interview, EP Lab Digest talks with Tracy Kane Lofty, MSA, CAE and Charles J. Love, MD about the changes being made in certification testing by the International Board of Heart Rhythm Examiners (IBHRE) amid the COVID-19 pandemic.
Kelly Airey, MD, FHRS, FACC shares their experience managing cases at Cardiovascular Medicine, P.C. and Genesis Health System during the COVID-19 pandemic.
Makoto Ono, MD, PhD and colleagues describe how precision medicine has the promise of improving the diagnostic and therapeutic value of genetic testing. This article briefly summarizes the history of precision medicine in LQTS.
Sumit Verma, MD shares follow-up data on their same-day discharge protocol for atrial fibrillation ablation cases.
Jonathan Salcedo, MD, FACC, FHRS describes an ultrasound-guided approach to medial axillary vein access for all transvenous CIED needs, including single- or dual-chamber PPMs, ICDs, and CRT-D/CRT-P devices.
Payam Safavi-Naeini, MD and colleagues review new studies taking place at the Texas Heart Institute as well as provide a progression update about ongoing studies in the lab.
This month, Katia Dyrda, MD and Laurent Macle, MD highlight the Montreal Heart Institute in Montreal, Quebec.
Lorraine Buck, VP and Jori Richardson, COO, RN describe how electrophysiologists at Naples Heart Rhythm Specialists, P.A. took a progressive outpatient approach to managing atrial fibrillation.
Khaldoun G. Tarakji, MD, MPH discusses this new era of healthcare delivery. Understanding these devices and their potential values is an important investment in caring not only for the patients of today, but certainly for the patients of tomorrow.